Lataa...
Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019
This cross-sectional study characterizes the premarket clinical evidence supporting clearance of moderate-risk novel therapeutic medical devices by the US Food and Drug Administration.
Tallennettuna:
| Julkaisussa: | JAMA Intern Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Medical Association
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7551221/ https://ncbi.nlm.nih.gov/pubmed/33044513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.3214 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|